Novozymes A/S Denmark
Based in Berlin, Novozymes A/S Denmark specialises in research and development into probiotics for the food-processing industry, pharmaceuticals, health, animal and human nutrition.
Novozymes A/S Denmark offers probiotics having a beneficial effect on gastrointestinal health.
Founded in 2001, the company relies on its own collection of strains to develop and market unique, effective and patentable products.
It has a diverse collection of yeasts and lactobacilli, the first of which date back to the 1920s.
Since September 2016, Novozymes A/S Denmark, formerly called Organobalance, has been part of the Novozymes group, leader in the field of biotechnology and a specialist in enzymes.